• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Research

Independent equity research and analysis from our analyst team

Research

Independent equity research and analysis from our analyst team

Solwers: Covenant knot tightens as earnings development falters
Research6/18/2026, 7:08 AM by
Olli Vilppo

Solwers: Covenant knot tightens as earnings development falters

Solwers withdrew its guidance yesterday, suggesting that a critical earnings improvement may not materialize this year. We lowered our estimates.

Solwers
Talenom extensive report: Finland stands firm, international turnaround is key
Extensive research6/18/2026, 2:39 PM by
Juha Kinnunen

Talenom extensive report: Finland stands firm, international turnaround is key

Talenom's Finnish core business continues to reliably generate strong cash flow, but investors doubt the sensibility of international growth. Profitability turnarounds in Spain and Sweden could also reverse the share price development.

Talenom
Finnair omfattende analyse: Mod rentabel vækst på blåhvide vinger
Extensive research6/17/2026, 6:23 PM by
Antti Viljakainen, Kaisa Vanha-Perttula

Finnair omfattende analyse: Mod rentabel vækst på blåhvide vinger

I sin nye strategiperiode sigter Finnair mod rentabel vækst og styrkelse af non-ticket-indtægter, samtidig med at selskabet gennemfører en fornyelse af sin flåde af smalle fly.

Finnair

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Scanfil extensive report: Good quality with full short-term pricing
Research6/17/2026, 3:52 PM by
Antti Viljakainen

Scanfil extensive report: Good quality with full short-term pricing

We raise our target price for Scanfil to EUR 12.50 (was 11.50 €) on the heels of slightly increased long-term growth estimates. Following the robust progress of the share price over the past year, the positive earnings growth projected in our forecasts has already been factored into the share. In our view, this narrows Scanfil's short-term expected return, even though the long-term story remains quite attractive.

Scanfil
H&M Q2'26 preview: Soft topline, but margins resilient so far
Research6/17/2026, 4:30 AM by
Lucas Mattsson

H&M Q2'26 preview: Soft topline, but margins resilient so far

We believe revenue growth remained soft in H&M's Q2, driven by weak market data, reflecting softer consumer confidence and cold weather in April.

H&M
Oriola omfattende analyse: Tålmodighed er opskriften
Extensive research6/17/2026, 4:30 AM by
Rauli Juva

Oriola omfattende analyse: Tålmodighed er opskriften

Oriola-aktien ser billig ud, men der er klare risici forbundet med både balancen og den operationelle drift.

Oriola
Kreate: Strong outlook materializes into growth
Research6/17/2026, 6:20 AM by
Atte Jortikka

Kreate: Strong outlook materializes into growth

We find the pricing still seems reasonable, considering our significantly raised earnings estimates and the expectation of substantial earnings growth.

Kreate Group
KPY: Succesfuld børsnotering midt i en strategisk transformation
Extensive research6/16/2026, 6:42 AM by
Frans-Mikael Rostedt

KPY: Succesfuld børsnotering midt i en strategisk transformation

KPY er i øjeblikket ved at skifte fra en traditionel balancesinvesteringsvirksomhed til en hybrid af en balancesinvesteringsvirksomhed og en fondsforvalter, da de rejser en ny kapitalfond og også sigter mod infrastrukturfonde.

KPY
Admicom: Mindre nedjustering af estimaterne
Research6/16/2026, 4:00 AM by
Atte Riikola

Admicom: Mindre nedjustering af estimaterne

Under opkaldet forud for den stille periode blev den seneste nedjustering diskuteret.

Admicom
Nightingale: We factored the project delay into our estimates
Research6/12/2026, 7:20 AM by
Antti Siltanen, Antti Luiro

Nightingale: We factored the project delay into our estimates

The revenue outlook for the next fiscal year exceeds 10 MEUR.

Nightingale Health
Puuilo Q1'26: Spot on
Research6/12/2026, 6:09 AM by
Arttu Heikura

Puuilo Q1'26: Spot on

Virtually all of the company's key metrics developed in a more positive direction.

Puuilo
Kemira: Stigende omkostninger udhuler rentabiliteten
Research6/11/2026, 5:10 AM by
Petri Gostowski

Kemira: Stigende omkostninger udhuler rentabiliteten

Kemira udstedte en nedjustering onsdag, hvilket skyldes en stigning i råvare- og transportomkostninger forårsaget af krigen i Iran.

Kemira
Suominen: Share issue in figures, valuation still high
Research6/11/2026, 6:12 AM by
Rauli Juva

Suominen: Share issue in figures, valuation still high

We updated the impact of the share issue on our estimates, but operationally our assumptions remained unchanged.

Suominen
Hafnia (Investment case): Q1 2026 delivers strong cash flow and dividends amid geopolitical disruption
Research6/10/2026, 2:10 PM by
Rasmus Køjborg, William Jørck

Hafnia (Investment case): Q1 2026 delivers strong cash flow and dividends amid geopolitical disruption

Following Hafnia's Q1 2026 quarterly report, we have updated our investment case on the company. Our updated investment case covers the key investment reasons, risks, and valuation perspective relative to product tanker peers.

Hafnia
Sitowise Group: Divestment drops Swedish millstone
Research6/10/2026, 7:14 AM by
Olli Vilppo

Sitowise Group: Divestment drops Swedish millstone

Sitowise announced yesterday that it is selling its Swedish technical consulting operations to Sweco.

Sitowise Group
Keskisuomalainen omfattende analyse: Udbytte og den digitale omstilling i centrum af fortællingen
Extensive research6/10/2026, 4:10 AM by
Arttu Heikura

Keskisuomalainen omfattende analyse: Udbytte og den digitale omstilling i centrum af fortællingen

Investorhistorien er baseret på en vellykket digital omstilling og tilpasning af den aftagende aktivitet.

Keskisuomalainen
Duell omfattende analyse: På jagt efter et vendepunkt
Extensive research6/9/2026, 6:23 AM by
Tommi Saarinen

Duell omfattende analyse: På jagt efter et vendepunkt

Vi har opjusteret vores estimater for indeværende år, men balancesituationen forbliver stram.

Duell
Terveystalo: Optikeren søger yderligere styrker
Research6/9/2026, 4:00 AM by
Roni Peuranheimo

Terveystalo: Optikeren søger yderligere styrker

Med opkøbene af Silmäasema og Hohde er Terveystalo ved at bevæge sig fra en stabil udbyttebetaler til en mere vækstorienteret retning.

Terveystalo
Danske Bank (Investment case): Q1 2026 confirms resilient earnings as Forward '28 raises the bar
Research6/8/2026, 3:08 PM by
Rasmus Køjborg, William Jørck

Danske Bank (Investment case): Q1 2026 confirms resilient earnings as Forward '28 raises the bar

Following Danske Bank's Q1 2026 interim report, we have updated our investment case on the company. Our updated investment case covers the key investment reasons, risks, and valuation perspective relative to peers across Nordic large-cap banking.

Danske Bank
Aurora Group Intiation of Coverage: Monitoring of Northern Lights starts
Extensive research6/8/2026, 8:44 AM by
Olli Vilppo

Aurora Group Intiation of Coverage: Monitoring of Northern Lights starts

Auroora's compounder story is in its early stages, but the company's playbook for achieving ambitious targets is in order.

Auroora Group